Acute toxicity following prostate radiotherapy was statistically significantly associated with late toxicity and with decrement in patient-reported QOL metrics. These data support efforts to evaluate whether interventions that reduce acute toxicity ultimately reduce the risk of late toxicity.
Severe hemophilia A is managed with factor VIII replacement or hemostatic products that stop or prevent bleeding. Data on gene therapy with hematopoietic stem-cell (HSC)–based…
Speakers: Arthur Bobin Titouan Cazaubiel Thomas Chalopin Bernard Delcour Laurent Gillot Mohamad Mohty Description: Rejoignez-nous pour un webinar dédié aux patients atteints de myélome et…
People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of zenocutuzumab for NSCLC with an NRG1 fusion. NRG1…
For patients aged 50 years or older and at 3 years post diagnosis, less frequent mammograms were non-inferior compared with annual mammograms for breast cancer-specific…
Clinical trials find one-time gene therapy exa-cel offers ‘functional cure’ in 96.6% of patients
No one has a greater stake in your healthcare than you do.
What the ingredients in a tube of toothpaste mean for your teeth and gums.
Grantee accounts remain frozen, while union accuses NSF of ignoring rules governing peer review
Objective: The primary aim of this study was to examine the association between the different predicted phenotypes of the polymorphic CYP2D6 gene and the prevalence…
